Additional Info on Pivotal’s Backstop
by Kristi Marvin on 2019-11-13 at 2:14pm

Yesterday, Pivotal Acquisition Corp. (PVT),  announced that it had entered into a commitment letter with MGG Investment Group, LP (“MGG”), where Pivotal may borrow up to $150 million of 5-year convertible notes, thus providing a backstop to their business combination with KLDiscovery.  However, there seemed to be some confusion as to just “how much” they’re backstopping.

If you looked at the proxy that was filed the same day, there was language within it that implied the $150 million convertible note was IN ADDITION to the $50 million forward purchase agreement (also with MGG), which would have provided for up to $200 million of backstop, less transaction expenses of ~$19 million.  For instance:

“(b)    the term “Available Closing Date Cash” means, as of immediately prior to the Closing, an aggregate amount equal to the result of (without duplication): (i) the cash available to be released from the Trust Account and the aggregate net cash proceeds actually received from any investment in Parent approved after the date hereof pursuant to Section 4.1(f), including up to $50,000,000 pursuant to the Forward Purchase Contract (if any), minus (ii) the aggregate amount of all redemptions of Parent Common Stock by any Redeeming Stockholders; minus (iii) the Outstanding Parent Expensesminus (iv) to the extent not included in the Outstanding Parent Expenses, the sum of all outstanding deferred, unpaid or contingent underwriting, broker’s or similar fees, commissions or expenses owed by Parent or any other party to the extent Parent or any of its Subsidiaries is responsible for or obligated to reimburse or repay any such amounts, minus (v) the aggregate amount outstanding under all indebtedness for borrowed money of Parent or Merger Sub (including any Parent Borrowings);”

However, it has now been suggested (on good authority) that the new $150 million convertible note should be considered “in lieu” of the $50 million forward purchase and the language was just a hold over from a previous filing.  As a result, Pivotal would need $25 million to remain in trust in order to satisfy the $175 million available cash at closing condition ($175M – $150M = $25M).  That’s not “fully backstopped”, but it’s still a pretty good backstop for a $233 million SPAC.

However, there’s still an itch that needs to be scratched – are the transaction expenses to be included or excluded? There seems to be a consensus among the SPAC community that it’s not included and Pivotal only need $25 million in trust post-vote.  Maybe we’ll get a revised proxy where they clean up the language so we can all have final clarity.  Additionally, maybe they left in the $50 million Forward Purchase Agreement language in case they need to use it (in a worst case scenario where redemptions leave less than $25 million remaining in trust).

For now, everyone is working with the $25 million cash left in trust post-redemptions figure.  If that changes, an update will be provided.

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved